Results 21 to 30 of about 337,094 (289)

Exercise training for intermittent claudication: a narrative review and summary of guidelines for practitioners

open access: yesBMJ Open Sport & Exercise Medicine, 2020
Peripheral artery disease (PAD) is caused by atherosclerotic narrowing of the arteries supplying the lower limbs often resulting in intermittent claudication, evident as pain or cramping while walking.
A. Harwood   +7 more
semanticscholar   +1 more source

Isokinetic strength and endurance in peripheral arterial insufficiency with intermittent claudication.

open access: yesScandinavian Journal of Rehabilitation Medicine, 2020
Isokinetic plantar flexor peak torques (PT) and contractional work (CW) of the triceps surae muscle have been measured in 24 patients with peripheral arterial insufficiency and intermittent claudication and in 15 controls.
Björn Gerdle   +3 more
semanticscholar   +1 more source

Absence of Long-term Benefit of Revascularization in Patients With Intermittent Claudication: Five-Year Results From the IRONIC Randomized Controlled Trial

open access: yesJournal of Vascular Surgery, 2020
Background: The long-term benefit of revascularization for intermittent claudication is poorly understood. The aim of this study was to investigate the long-term effectiveness and cost-effectiveness compared with a noninvasive approach.
Henrik Djerf   +5 more
semanticscholar   +1 more source

Prediction of the effect of training on the walking tolerance in patients with intermittent claudication.

open access: yesScandinavian Journal of Rehabilitation Medicine, 2020
The possibility of predicting the effect of training on the walking tolerance in intermittent claudication has been studied. After three months of supervised training in 54 patients, the maximal walking distance (MWD) increased by 67% and the painfree ...
T. Jonason, I. Ringqvist
semanticscholar   +1 more source

Intermittent Claudication and Asymptomatic Peripheral Arterial Disease.

open access: yesDeutsches Ärzteblatt International, 2020
BACKGROUND The conservative treatment of peripheral arterial disease (PAD), as recommended in current guidelines, encompasses measures such as lifestyle modification and risk-factor management.
G. Rümenapf   +3 more
semanticscholar   +1 more source

Rivaroxaban with Aspirin Versus Aspirin for Peripheral Arterial Disease and Intermittent Claudication. Rationale and Design of the COMPASS CLAUDICATION Trial

open access: yesClinical and Applied Thrombosis/Hemostasis, 2022
Background The COMPASS trial demonstrated that in patients with peripheral arterial disease, the combination of rivaroxaban and aspirin compared with aspirin reduces the risk of major adverse limb events, but it is not known whether this combination can ...
Eduardo Ramacciotti MD, PhD   +16 more
doaj   +1 more source

The Bambuí health and aging study (BHAS). Prevalence of intermittent claudication in the aged population of the community of Bambuí and its associated factors

open access: yesArquivos Brasileiros de Cardiologia, 2001
OBJECTIVE: To assess the prevalence of intermittent claudication in the aged population of Bambuí, Brazil, and to identify the factors associated with this disease.
Valéria Maria de Azeredo Passos   +5 more
doaj   +1 more source

Gait pattern in patients with peripheral artery disease

open access: yesBMC Geriatrics, 2018
Background The aim of the present paper is to assess the gait pattern of patients with Peripheral Artery Disease (PAD). A more specific aim is to compare the gait pattern of PAD patients before and after the appearance of intermittent claudication ...
Maria Szymczak   +3 more
doaj   +1 more source

Effect of supervised exercise on physical function and balance in patients with intermittent claudication [PDF]

open access: yes, 2014
Background The aim of the study was to identify whether a standard supervised exercise programme (SEP) for patients with intermittent claudication improved specific measures of functional performance including balance. Methods A prospective observational
Chetter, I. C.   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy